Abstract

The Thai temporary National Assembly passed the Protection for Children Born through Assisted Reproductive Technologies Act, 2015 on February 19, 2015. The passing of Thailand’s law regulating reproductive medicine was followed by an enactment with the approval of the cabinet and King Bhumibol Adulyadej in July 2015. Since then, some surrogacy mediation agencies based in Thailand, including Japanese surrogacy agencies, have shifted their attention from Thailand to other Asian countries, such as Cambodia, Georgia and others. This paper discusses the background of the rapid growth of the Cambodian surrogacy industry as well as the government’s announcement of a complete ban on commercial surrogacy, and also the risks inherent in Cambodian surrogacy business. This paper aims to provide related information to Japanese surrogacy patients and researchers in reproductive medicine.